SCHEMBL12419565

SCHEMBL12419565

OB(O)c1ccc(-c2nnc(-c3ccc4c(c3)OCO4)o2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.67
▸ RAB9A P51151 9/20 0.67
▸ KDM4E B2RXH2 8/20 0.67
▸ SMN1; SMN2 Q16637 7/20 0.67
▸ MAPT P10636 6/20 0.67
▸ ALDH1A1 P00352 5/20 0.67
▸ TP53 P04637 4/20 0.57
▸ HSD17B10 Q99714 4/20 0.57
▸ POLB P06746 3/20 0.57
▸ TSHR P16473 3/20 0.57
▸ HPGD P15428 2/20 0.57
▸ GAA P10253 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ ALOX15 P16050 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ NFKB1 P19838 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3492339 0.86 NPC1 (0.81) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL12797796 0.78 NPC1 (0.65) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL12419575 0.77 ALDH1A1 (0.44) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL31040512 0.75 NPC1 (0.65) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL391671 0.75 NPC1 (0.65) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL24653524 0.75 NPC1 (0.65) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL30622710 0.75 NPC1 (0.65) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL29956957 0.75 CYP3A4 (0.54) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL30231 0.75 CYP3A4 (0.54) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL17055725 0.75 KDM4E (0.60) NPC1RAB9AKDM4ESMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 NPC1 472/4885RAB9A 1820/4885KDM4E 1442/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 NPC1 472/4885RAB9A 1820/4885KDM4E 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback